Log in to search using one of your social media accounts:

 

Emory ’s Sharron Close started clinic for patients with X & Y chromosome variations
For many years, families affected by X and Y chromosome variations had few treatment and research options. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 19, 2018 Category: Biotechnology Authors: Tonya Layman Source Type: news

Kauai's first medical marijuana dispensary approved for sales
The Hawaii Department of Health gave the green light to Kauai ’s first medical marijuana dispensary to begin sales immidiately. The DOH said Green Aloha Ltd., dba Have a Heart, completed laboratory testing requirements and passed the final onsite inspection of its retail facility.  The dispensary, located at 4-1565​ ​Kuhio​ ​Highway in Kapaa, is t he sixth licensed medical cannabis dispensary in Hawaii to receive approval to begin sales of medical cannabis to registered patients and caregivers. “Having… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 19, 2018 Category: Biotechnology Authors: Anna Hrushka Source Type: news

UC Davis Health names new CEO
UC Davis Health is under new leadership. David A. Lubarsky was named as the system's new CEO and as vice chancellor of human health sciences for University of California Davis, the university said in a news release Friday. He will start July 2. Lubarsky will be responsible for overseeing the schools of medicine and nursing, UC Davis Me dical Center and the hospital’s primary care network. He will work closely with UC Davis Medical Center CEO Ann Madden Rice, the university said. Prior to joining… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 18, 2018 Category: Biotechnology Authors: Kayla Webster Source Type: news

Kaiser Permanente commits $200 million to fight homelessness and support affordable housing
Kaiser Permanente has pledged up to $200 million to fight homelessness and support affordable housing in one of the biggest individual financial commitments on the issue from a private enterprise. While it’s currently unclear what exact programs will be funded using the money, Kaiser’s Chief Community Health Officer Bechara Choucair said the goal is to partner with local communities and community groups to help support existing solutions that are working to preserve and expand affordabl e housing.… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 18, 2018 Category: Biotechnology Authors: Kevin Truong Source Type: news

Kilroy nears deal for Chinese developer's huge South S.F. biotech project
Kilroy would be the third developer to take on the potential $2 billion Landing at Oyster Point. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 18, 2018 Category: Biotechnology Authors: Ron Leuty Source Type: news

Kilroy nears deal for Chinese developer's huge South S.F. biotech project
Kilroy would be the third developer to take on the potential $2 billion Landing at Oyster Point. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - May 18, 2018 Category: Health Management Authors: Ron Leuty Source Type: news

Kaiser Permanente commits $200 million to fight homelessness and support affordable housing
Kaiser Permanente has pledged up to $200 million to fight homelessness and support affordable housing in one of the biggest individual financial commitments on the issue from a private enterprise. While it’s currently unclear what exact programs will be funded using the money, Kaiser’s Chief Community Health Officer Bechara Choucair said the goal is to partner with local communities and community groups to help support existing solutions that are working to preserve and expand affordabl e housing.… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 18, 2018 Category: Biotechnology Authors: Kevin Truong Source Type: news

Report analyzes impact on health insurance rates in Oregon from 'marketplace sabotage'
Oregon will feel less of an impact, since the state limits short-term plans. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 18, 2018 Category: Biotechnology Authors: Elizabeth Hayes Source Type: news

Gaithersburg biotech faces threat of stock delisting
Key highlights: Altimmune received a warning from Nasdaq about a potential delisting because its stock price is too low. The company has until mid-November to gain compliance with the exchange. The news comes not long after Altimmune had merged with PharmAthene and expanded its Gaithersburg headquarters space. Altimmune Inc. has been put on notice that its stock could be delisted from the Nasdaq exchange if it cannot raise its share price consistently above $1 in the next six months. The Gaithersburg… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 18, 2018 Category: Biotechnology Authors: Vandana Sinha Source Type: news

Gaithersburg biotech faces threat of stock delisting
Key highlights: Altimmune received a warning from Nasdaq about a potential delisting because its stock price is too low. The company has until mid-November to gain compliance with the exchange. The news comes not long after Altimmune had merged with PharmAthene and expanded its Gaithersburg headquarters space. Altimmune Inc. has been put on notice that its stock could be delisted from the Nasdaq exchange if it cannot raise its share price consistently above $1 in the next six months. The Gaithersburg… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - May 18, 2018 Category: Health Management Authors: Vandana Sinha Source Type: news

Kaiser Permanente commits $200 million to fight homelessness and support affordable housing (video)
Kaiser Permanente has pledged up to $200 million to fight homelessness and support affordable housing in one of the biggest individual financial commitments on the issue from a private enterprise. While it’s currently unclear what exact programs will be funded using the money, Kaiser’s Chief Community Health Officer Bechara Choucair said the goal is to partner with local communities and community groups to help support existing solutions that are working to preserve and expand affordabl e housing.… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 18, 2018 Category: Biotechnology Authors: Kevin Truong Source Type: news

Licensing, partnerships drive Moffitt financial gains
H. Lee Moffitt Cancer Center& Research Institute Inc. reported financial gains for the three months ended March 31. Moffitt’s income from operations for the quarter ended March 31 was $22.2 million compared to $4.1 million for the first three months of 2017, according to the cancer center's quarterly report. For the nine months ended March 31, Moffitt reported more than $54.4 million in income from operations compared to nearly $29 million for the same period a year earlier.  Based in Tampa… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 18, 2018 Category: Biotechnology Authors: Frances McMorris Source Type: news

4 risks digital health companies need to face head-on
Digital health care companies are leading the revolution in consumer-centric healthcare, but the promise of breakthrough innovation and better patient outcomes won ’t be fully realized without a systematic approach to risk identification and management. Made possible by low-cost technology, abundant venture capital and the Internet of Things (IoT), digital healthcare companies are creating new business models and service delivery options. But in reshaping t he industry, digital health care companies… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 18, 2018 Category: Biotechnology Authors: Brett Buchanan Source Type: news

Top of the List: Leading physicians groups in Kansas City
This week, the Kansas City Business Journal ranks Kansas City's physicians groups. And this year, there's been some movement among the top ranks. The accompanying gallery shows the top five on The List, ranked by number of physicians. For the full List, subscribers can take a look at the weekly print edition of the Kansas City Business Journal. The List also includes address, phone number, number of physicians, a list of each group's medica l specialties and chief administrator. (Subscribers also… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 18, 2018 Category: Biotechnology Authors: Vicky Diaz-Camacho Source Type: news

For $26M, The Cardinal at North Hills wants to add more beds
For The Cardinal at North Hills, growth has been the name of the game recently. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 18, 2018 Category: Biotechnology Authors: Jennifer Henderson Source Type: news

Franklin health firm unveils new name ahead of national launch
A Franklin-based health care startup has changed its name as well as some of its senior leadership. Precera Bioscience Inc., formerly Sano Informed Prescribing, was co-founded in 2015 by Tim Ryan, a veteran of pharmaceutical giant Eli Lilly, to focus on how blood tests could determine how medications impact patients. Ryan co-founded the company with his brother, Doug Ryan, a vice president with Colliers International, and experienced health care executive Murray Blackshear. CEO Pamela Weir, who… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 18, 2018 Category: Biotechnology Authors: Joel Stinnett Source Type: news

Evergreen Health, UBMD partner on new HIV trial
Two HIV-positive Buffalo patients will be among the first in the nation to try a new treatment that reduces their medication regimen from daily pills to just once a month. Access to the injectable medication comes through a clinical trial taking place at Evergreen Health's downtown facility and the University at Buffalo Department of Medicine’s HIV and infectious disease division in conjunction with UBMD Internal Medicine. It’s part of a broader collaboration b etween Evergreen Health and UBMD… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 18, 2018 Category: Biotechnology Authors: Tracey Drury Source Type: news

Former Baptist Healthcare CEO dies
Tommy Smith, a former CEO of Baptist Healthcare System Inc., died Thursday. Smith retired from Baptist Health in 2013 after 37 years with the organization. He was CEO for 18 years. During his tenure, he led three of the organization's hospitals, now known as Baptist Health Lexington, Baptist Health Louisville and Baptist Health La Grange. While he was CEO, Baptist Healt hcare's revenue increased from $400 million company to more than $1.6 billion. Smith's age and the cause of his death were not… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 18, 2018 Category: Biotechnology Authors: Carolyn Tribble Greer Source Type: news

Keystone First looks to Lyft to get poor, pregnant patients to appointments
For many low-income patients, getting to the doctor for regular checkups can be a challenge. It can be hard to take off from work, and it can be even harder to find a ride to the hospital — especially in an emergency. Enter: ride-hailing services, Uber and Lyft, which have entered the healthcare space as public health experts and practitioners look for ways to reduce transportation barriers. Medicaid provider AmeriHealth Caritas District of Columbia has already tested a program u sing Lyft for… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 18, 2018 Category: Biotechnology Authors: Dana Bate Source Type: news

AHN announces plan for $15 minimum wage by 2021
Allegheny Health Network plans to raise its minimum wage for employees to $15 per hour by 2021. The health system's decision "reflects the network’s ongoing assessment of the market and commitment to providing a highly competitive compensation and benefits packages for employees at every level," according to a news release. AHN operates eight hospitals, four health and wellness pavilions and hundreds of other care sites in western Pennsylvania, employing about 19,000 people. “Allegheny Health… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 18, 2018 Category: Biotechnology Authors: Stacey Federoff Source Type: news

Core values drive Phoenix Home Care ’s work
Phoenix Home Care& Hospice was a finalist at the 2018 Best In Business Awards. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 18, 2018 Category: Biotechnology Source Type: news

SLU Hospital president leaving for New Mexico hospital
Kate Becker, a St. Louis native, has been president of SSM Health Saint Louis University Hospital since July 2015. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 18, 2018 Category: Biotechnology Source Type: news

UT Health SA gets millions from state to bring talent back home
UT Health San Antonio has been awarded $6 million in grant funding from the Cancer Prevention and Research Institute of Texas, which enabled the local institution to recruit a leading researcher and professor. UT Health San Antonio is using the money — which was among $30 million across nine new grants awarded by CPRIT — to recruit Dr. Patrick Sung, professor of biophysics, biochemistry, therapeutic radiology and epidemiology at Yale University. He will occupy the Robert A. Welch Distinguished… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 18, 2018 Category: Biotechnology Authors: W. Scott Bailey Source Type: news

Lexington biotech startup homes in on a new kind of precision cancer drug
When Robert Copeland explains the science behind his new cancer drug startup, Accent Therapeutics, he uses the analogy of building a house: an architect makes a blueprint, and a builder translates it into a physical structure. That ’s also how cellular biology works, he says: DNA is transcribed into RNA, which produces proteins. But as in the case of building a house, it’s a little more complicated than that. Just as a homeowner will make modifications to put their personal stamp on a property… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 18, 2018 Category: Pharmaceuticals Authors: Max Stendahl Source Type: news

Nationwide nursing shortage opens up career opportunities
Grand Canyon University is ready to help fill those vacant positions. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 18, 2018 Category: Biotechnology Authors: Angela Gonzales Source Type: news

US opioid crisis hits Indian pharma companies
The total market size of opioid-based painkillers is estimated at $24 billion, with Fentanyl and Oxycontin being some of the commonly prescribed drugs. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 18, 2018 Category: Pharmaceuticals Source Type: news

Stempeutics partners with Cipla for its stem cell drug
Founded in 2006 by Manipal Education and Medical Group (MEMG), Stempeutics later entered into an alliance with Cipla in 2009. It is an advanced clinical stage biotech firm. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 18, 2018 Category: Pharmaceuticals Source Type: news

Gingerich joins Michael Best & Friedrich
Lisa Gingerich, who previously was a shareholder in the health law section at von Briesen& Roper SC in Milwaukee, joined Michael Best& Friedrich LLP ’s transactional practice group in Milwaukee with a focus on health care law. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 17, 2018 Category: Biotechnology Authors: Rich Kirchen Source Type: news

UCF clinic receives $10 million to expand PTSD treatment and research program to military installations
University of Central Florida's cutting-edge clinic that helps people who are suffering from post-traumatic stress disorder was awarded a $10 million grant to establish programs at three military installations in the Southeastern U.S. The U.S Army funded UCF’s Restores clinic to expand its program that combines virtual-reality and exposure therapy with group treatments to Dwight D. Eisenhower Army Medical Center in Georgia, Naval Medical Hospital Portsmouth in Virginia and Marine Corps Base Camp… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 17, 2018 Category: Biotechnology Authors: Anjali Fluker Source Type: news

​FDA names and shames drugmakers to encourage generic competition
The FDA says it will crack down on drug companies that are “gaming the system” in order to thwart generic manufacturers from bringing products to market. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 17, 2018 Category: Biotechnology Authors: Sheila Kaplan Source Type: news

Giant VA contract comes through for Cerner
After months of delays, the Department of Veterans Affairs signed its $10 billion contract with Cerner Corp. Acting VA Secretary Robert Wilkie announced that the contract had been signed Wednesday afternoon, making Cerner (Nasdaq: CERN) the holder of "one of the largest IT contracts in the federal government." Wilkie said the contract would have a ceiling of $10 billion over 10 years. Congress allocated $782 million for the effort in fiscal year 2018. "And with a contract of that size, you can… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 17, 2018 Category: Biotechnology Authors: Elise Reuter Source Type: news

Critical Condition: Declining NIH money threatens San Antonio's economic future
The Alamo City has seen its annual share of funding from the National Institutes for Health for medical research decline by more than $28 million since 2012. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 17, 2018 Category: Biotechnology Authors: W. Scott Bailey Source Type: news

This scientist-led startup is working on a cure for a common surgery complication
A complication from surgery can cost tens of thousands of dollars and require more surgery to correct — but a young Maryland startup is cooking up a more affordable and less invasive solution. Bethesda's Nostopharma LLC is developing a treatment for pathologic bone growth, the formation of new bone following surgeries, burns, injuries and other traumas. The complication affects 100,000 patients e very year, a patient cohort the company’s co-founders hope to benefit with their product. The partners,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 17, 2018 Category: Biotechnology Authors: Sara Gilgore Source Type: news

Aon selects Bellevue-based Mpirica to provide clients with more health care transparency
This is part of an effort by Aon to provide the best information to its employer customers as the look for new ways to manage the effectiveness and cost of health care expenditures. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 17, 2018 Category: Biotechnology Authors: Coral Garnick Source Type: news

StemBioSys raises $4.3M; sees itself as a “different company” ready to leverage new funding
The San Antonio biotech has locked in more than $4 million in additional investor funding to help expand its brand and product line. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 17, 2018 Category: Biotechnology Authors: W. Scott Bailey Source Type: news

StemBioSys raises $4.3M; sees itself as a “different company” ready to leverage new funding
The San Antonio biotech has locked in more than $4 million in additional investor funding to help expand its brand and product line. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 17, 2018 Category: Pharmaceuticals Authors: W. Scott Bailey Source Type: news

Gilead, BioMarin among Bay Area drug makers shamed by FDA in generics 'gaming' list
Calling it an effort to bring transparency to the development of low-cost generic drugs, the Food and Drug Administration on Thursday released a list of drug developers who have received requests from generic drug makers for access to the branded drugs. The agency said it has not independently investigated or confirmed that brand-name drug makers listed in a post to the agency's website limited access to samples of the branded drugs. But the list is an unusual public shaming by the agency of several… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 17, 2018 Category: Biotechnology Authors: Ron Leuty Source Type: news

Viewpoint: China has the upper hand in cancer cell therapy
Cheers went up last August when the U.S. Food and Drug Administration approved the world ’s first CAR-T cancer cell treatment, Novartis’ Kymriah, and again in October when it approved Gilead’s CAR-T treatment for non-Hodgkin's lymphoma. In CAR-T therapy, the immune system’s killer T cells are modified to target specific tumors, giving physicians a powerful new tool to treat canc er. But when it comes to the long-term development of this revolutionary treatment, China is poised to leapfrog… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 17, 2018 Category: Biotechnology Source Type: news

Biogen, Shire called out by FDA for ‘gaming’ generic access rule
The FDA on Thursday released a list of more than three dozen drugmakers that it said have been accused of using “gaming tactics" to block other firms from developing generic versions of their products. Among those named: Biogen Inc. and Shire plc, two of the largest drug companies in Massachusetts. The FDA’s decision to publish the list is part of a broader effort by the Trump administration to drive dow n the cost of brand name drugs. The agency identified 39 companies that have been the subject… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 17, 2018 Category: Biotechnology Authors: Max Stendahl Source Type: news

HBJ announces rankings of Houston ’s Healthiest Employers
The Houston Business Journal has revealed the rankings of the 31 local offices that have put an emphasis on employee health care and wellness offerings. Each company was surveyed and put into one of four categories — small, medium, large and extra large — based on their total employee count. Click through the gallery above to see the companies’ rankings, score, indexed score and local employee count.  The highest-ranked company in each cat egory was: Small, 2-499 employees: Sense Corp. Medium,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 17, 2018 Category: Biotechnology Authors: Jen Para Source Type: news

New filing reveals Cigna's plans for Express Scripts
Express Scripts will remain in St. Louis following the company's sale to Connecticut-based Cigna, according to a securities filing Wednesday. The $67 billion deal was announced in March and is expected to close before the end of the year. The Express Scripts unit, to be led by current CEO Tim Wentworth, will continue to operate independently, the filing said. Wentworth will be the president of the Express Scripts division, reporting into the combined company’s CEO. Four of Express Scripts' current… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 17, 2018 Category: Biotechnology Authors: Jacob Kirn Source Type: news

Orthopedic urgent care clinic opens first Alabama location in Birmingham
An orthopedic urgent care clinic has made its Alabama debut in the metro Birmingham area. OrthoExpress opened its first Birmingham location in Chelsea, according to 280 Living. The clinic has five more locations planned for central Alabama. OrthoExpress is located at 104 Chelsea Pointe. It is open from 10 a.m. to 8 p.m. Monday through Friday and from 1 p.m. to 6 p.m. Saturday through Sunday. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 17, 2018 Category: Biotechnology Source Type: news

HCA Midwest poaches local cardiologist to start new Heart Rhythm Institute
HCA Midwest will build out its new heart rhythm institute with a notable hire. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 17, 2018 Category: Biotechnology Authors: Elise Reuter Source Type: news

NCCN expands management team with the hiring of its first chief medical officer
The National Comprehensive Cancer Network is expanding the management team at its Montgomery County headquarters. The NCCN, a nonprofit alliance of more than two dozen cancer centers from around the country, has hired Dr. Wui-Jin Koh for the newly created position of senior vice president and chief medical officer. Koh is radiation oncologist and professor who specializes in the treatment of gynecologic and gastrointestinal malignancies. He currently serves as medical director for radiation oncology… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 17, 2018 Category: Biotechnology Authors: John George Source Type: news

With sights on FDA approval, Liquidia recruits commercial exec
Morrisville-based biopharmaceutical company Liquidia Technologies has recruited a new commercial executive with its sights set on potential U.S. Food and Drug Administration approval.   Jeri Thomas – most recently senior vice president of strategic group planning at New York health care marketing agency Harrison and Star – has joined Liquidia as the company’s senior vice president of commercial.  Thomas has served as senior vice president of the surgical& perioperative care business unit … (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 17, 2018 Category: Biotechnology Authors: Jennifer Henderson Source Type: news

Why law school may be the next step for this recently retired health care CEO
This is Clearwater Compliance founder Bob Chaput's third attempt at retirement. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 17, 2018 Category: Biotechnology Authors: Joel Stinnett Source Type: news

UPMC, Philips, American Heart Association join forces for $30M venture capital fund
Cardeation Capital represents a new initiative in the AHA's efforts to foster even more innovation on the technical side of cardiovascular care, AHA CEO Nancy Brown said. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 17, 2018 Category: Biotechnology Authors: Paul J. Gough Source Type: news

International consortium wants to sequence the DNA of 1.5 million species
(Funda ç ã o de Amparo à Pesquisa do Estado de S ã o Paulo) The purposes and the challenges of Earth Biogenome Project, which aims at sequencing the genome from all eukaryotic species, are described in article at PNAS. Objectives include not only biodiversity conservation but also exploring biotechnology's broad applications, capable of generating great economic input - especially for developing countries boasting rich ecological heritage. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 17, 2018 Category: Biology Source Type: news

Winners of the 2018 Elsevier Foundation Green and Sustainable Chemistry Challenge
(Elsevier) Two new chemistry solutions that use guava leaves to combat food spoilage and turn fish bones into phosphate rich fertilizer won the Elsevier Foundation Green and Sustainable Chemistry Challenge. The 2018 first prize winner is Prajwal Rajbhandari, President of the Research Institute for Biosciences& Biotechnology in Nepal. The second prize was awarded to Dr. Alessio Adamiano. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 17, 2018 Category: Biology Source Type: news

As BIO convention nears, House passes major life science bill
The bill (H 4501) provides about $463 million in new capital authorizations for the state Life Sciences Capital Fund, and extends for another decade a life sciences tax incentive program currently scheduled to expire at the end of 2018. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 17, 2018 Category: Biotechnology Authors: Colin A. Young Source Type: news